294
Views
0
CrossRef citations to date
0
Altmetric
Review

Improving Physiological, Physical, and Psychological Health Outcomes: A Narrative Review in US Veterans with COPD

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1269-1283 | Published online: 01 Jun 2022

References

  • National Center for Veterans Analysis and Statistics. VA utilization profile FY2017. Available from: https://www.va.gov/vetdata/docs/Quickfacts/VA_Utilization_Profile_2017.pdf. Accessed May 20, 2022.
  • Wang ZJ, Dhanireddy P, Prince C, Larsen M, Schimpf M, Pearman G. 2019 survey of veteran enrollees’ health and use of health care. Available from: https://www.va.gov/HEALTHPOLICYPLANNING/SOE2019/2019_Enrollee_Data_Findings_Report-March_2020_508_Compliant.pdf. Accessed May 20, 2022.
  • Percentage distribution of household income in the US in 2020. Available from: https://www.statista.com/statistics/203183/percentage-distribution-of-household-income-in-the-us/. Accessed May 20, 2022.
  • Jamal A, Phillips E, Gentzke AS, et al. Current cigarette smoking among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(2):53–59. doi:10.15585/mmwr.mm6702a1
  • Pugh MJ, Jaramillo CA, Leung KW, et al. Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan. Mil Med. 2016;181(5):476–481. doi:10.7205/MILMED-D-15-00035
  • Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NA. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010;5:125–132. doi:10.2147/copd.s8047
  • Group TMoCOPDW. VA/DOD clinical practice guidelines for the management of chronic obstructive pulmonary disease. 2021.
  • Darnell K, Dwivedi AK, Weng Z, Panos RJ. Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost. Cost Eff Resour Alloc. 2013;11:13. doi:10.1186/1478-7547-11-13
  • Wheaton AG, Liu Y, Croft JB, et al. Chronic obstructive pulmonary disease and smoking status - United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(24):533–538. doi:10.15585/mmwr.mm6824a1
  • Murphy DE, Chaudhry Z, Almoosa KF, Panos RJ. High prevalence of chronic obstructive pulmonary disease among veterans in the urban midwest. Mil Med. 2011;176(5):552–560. doi:10.7205/MILMED-D-10-00377
  • Karel MJ, Wray LO, Adler G, et al. Mental health needs of aging veterans: recent evidence and clinical recommendations. Clin Gerontol. 2022;45(2):252–271. doi:10.1080/07317115.2020.1716910
  • Schüz N, Walters JA, Cameron-Tucker H, Scott J, Wood-Baker R, Walters EH. Patient anxiety and depression moderate the effects of increased self-management knowledge on physical activity: a secondary analysis of a randomised controlled trial on health-mentoring in COPD. COPD. 2015;12(5):502–509. doi:10.3109/15412555.2014.995289
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2022 report; 2021. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed December 20, 2021.
  • Bosse R, Sparrow D, Rose CL, Weiss ST. Longitudinal effect of age and smoking cessation on pulmonary function. Am Rev Respir Dis. 1981;123(4 Pt 1):378–381. doi:10.1164/arrd.1981.123.4.378
  • Breen M, Nwanaji-Enwerem JC, Karrasch S, et al. Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies. Aging. 2020;12(16):16539–16554. doi:10.18632/aging.103784
  • Bell B, Rose CL, Damon A. The Veterans Administration longitudinal study of healthy aging. Gerontologist. 1966;6(4):179–184. doi:10.1093/geront/6.4.179
  • Bosse R, Costa P, Cohen M, Podolsky S. Age, smoking inhalation, and pulmonary function. Arch Environ Health. 1975;30(10):495–498. doi:10.1080/00039896.1975.10666760
  • Mordukhovich I, Lepeule J, Coull BA, Sparrow D, Vokonas P, Schwartz J. The effect of oxidative stress polymorphisms on the association between long-term black carbon exposure and lung function among elderly men. Thorax. 2015;70(2):133–137. doi:10.1136/thoraxjnl-2014-206179
  • Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009;361(27):2599–2608. doi:10.1056/NEJMoa0904006
  • Renzetti AD, McClement JH, Litt BD. The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Aspen Emphysema Conf. 1968;9:367–378.
  • Dean NC, Brown JK, Himelman RB, Doherty JJ, Gold WM, Stulbarg MS. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis. 1992;146(4):941–945. doi:10.1164/ajrccm/146.4.941
  • Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest. 1975;68(4):486–492. doi:10.1378/chest.68.4.486
  • Long-Term Oxygen Treatment Trial Research Group. A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med. 2016;375(17):1617–1627. doi:10.1056/NEJMoa1604344
  • GROUP* NOTT. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391–398. doi:10.7326/0003-4819-93-3-391
  • Party MR. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981;1(8222):681–686.
  • Chetty KG, Despars JA, Giron A, Light RW. Conversion of COPD patients from multiple to single dose theophylline. Serum levels and symptom comparison. Chest. 1991;100(4):1064–1067. doi:10.1378/chest.100.4.1064
  • Berger R, Smith D. Effect of inhaled metaproterenol on exercise performance in patients with stable “fixed” airway obstruction. Am Rev Respir Dis. 1988;138(3):624–629. doi:10.1164/ajrccm/138.3.624
  • Jenne JW, Ridley DJ, Marcucci RA, Druz WS, Rook JC. Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline. Am Rev Respir Dis. 1982;126(4):607–610. doi:10.1164/arrd.1982.126.4.607
  • Ashutosh K, Dev G, Steele D. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease. Chest. 1995;107(1):173–178. doi:10.1378/chest.107.1.173
  • Beauford W, Saylor TT, Stansbury DW, Avalos K, Light RW. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest. 1993;104(1):175–178. doi:10.1378/chest.104.1.175
  • Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med. 1999;340(25):1941–1947. doi:10.1056/NEJM199906243402502
  • Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689–698. doi:10.1056/NEJMoa1104623
  • Lam J, Tonnu-Mihara I, Kenyon NJ, Kuhn BT. Comparative effectiveness of roflumilast and azithromycin for the treatment of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2021;8(4):450–463. doi:10.15326/jcopdf.2021.0224
  • Yeh SS, Phanumas D, Hafner A, Schuster MW. Risk factors for osteoporosis in a subgroup of elderly men in a Veterans Administration nursing home. J Investig Med. 2002;50(6):452–457. doi:10.1136/jim-50-06-05
  • Morden NE, Sullivan SD, Bartle B, Lee TA. Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int. 2011;22(6):1855–1862. doi:10.1007/s00198-010-1423-y
  • Cote CG, Pinto-Plata VM, Marin JM, Nekach H, Dordelly LJ, Celli BR. The modified BODE index: validation with mortality in COPD. Eur Respir J. 2008;32(5):1269–1274. doi:10.1183/09031936.00138507
  • Tunsupon P, Mador MJ. The influence of body composition on pulmonary rehabilitation outcomes in chronic obstructive pulmonary disease patients. Lung. 2017;195(6):729–738. doi:10.1007/s00408-017-0053-y
  • Nunez ER, Johnson SW, Qian SX, et al. Patterns of pulmonary consultation for veterans with incident chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2021;18(7):1249–1252. doi:10.1513/AnnalsATS.202008-1075RL
  • Fan VS, Gaziano JM, Lew R, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012;156(10):673–683. doi:10.7326/0003-4819-156-10-201205150-00003
  • Aboumatar H, Naqibuddin M, Chung S, et al. Effect of a hospital-initiated program combining transitional care and long-term self-management support on outcomes of patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. JAMA. 2019;322(14):1371–1380. doi:10.1001/jama.2019.11982
  • Ashton CM, Souchek J, Petersen NJ, et al. Hospital use and survival among Veterans Affairs beneficiaries. N Engl J Med. 2003;349(17):1637–1646. doi:10.1056/NEJMsa003299
  • Reese RL, Clement SA, Syeda S, et al. Coordinated-transitional care for veterans with heart failure and chronic lung disease. J Am Geriatr Soc. 2019;67(7):1502–1507. doi:10.1111/jgs.15978
  • Rinne ST, Elwy AR, Bastian LA, Wong ES, Wiener RS, Liu C-F. Impact of multisystem health care on readmission and follow-up among veterans hospitalized for chronic obstructive pulmonary disease. Med Care. 2017;55:S20–S25. doi:10.1097/mlr.0000000000000708
  • LaBedz SL, Krishnan JA, Chung YC, et al. Chronic obstructive pulmonary disease outcomes at veterans affairs versus non-veterans affairs hospitals. Chronic Obstr Pulm Dis. 2021;8(3):306–313. doi:10.15326/jcopdf.2021.0201
  • O’Donnell DE, Milne KM, James MD, De Torres JP, Neder JA. Dyspnea in COPD: new mechanistic insights and management implications. Adv Ther. 2020;37(1):41–60. doi:10.1007/s12325-019-01128-9
  • Hajghanbari B, Garland SJ, Road JD, Reid WD. Pain and physical performance in people with COPD. Respir Med. 2013;107(11):1692–1699. doi:10.1016/j.rmed.2013.06.010
  • Wan E, Goldstein R, Kantorowski A, Moy M. Association between exercise capacity and physical activity with long-term all-cause and cause-specific mortality among US veterans with COPD. In: TP41. TP041 DIAGNOSIS and RISK ASSESSMENT in COPD. American Thoracic Society; 2021:A2284–A2284.
  • Spruit MA, Pitta F, McAuley E, ZuWallack RL, Nici L. Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(8):924–933. doi:10.1164/rccm.201505-0929CI
  • Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD; Nett Research Group. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105–116. doi:10.1080/15412550801941190
  • Bamonti PM, Boyle JT, Goodwin CL, et al. Predictors of outpatient pulmonary rehabilitation uptake, adherence, completion, and treatment response among male US veterans with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2021. doi:10.1016/j.apmr.2021.10.021
  • Sahin H, Naz I. Why are COPD patients unable to complete the outpatient pulmonary rehabilitation program? Chron Respir Dis. 2018;15(4):411–418. doi:10.1177/1479972318767206
  • Major S, Moreno M, Shelton J, Panos RJ. Veterans with chronic obstructive pulmonary disease achieve clinically relevant improvements in respiratory health after pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2014;34(6):420–429. doi:10.1097/hcr.0000000000000079
  • Vorrink SN, Kort HS, Troosters T, Lammers J-WJ. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res. 2011;12(1):33. doi:10.1186/1465-9921-12-33
  • Gimeno-Santos E, Frei A, Steurer-Stey C, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69(8):731–739. doi:10.1136/thoraxjnl-2013-204763
  • Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir Soc. 2014;44:1521–1537. doi:10.1183/09031936.00046814
  • Moy ML, Collins RJ, Martinez CH, et al. An internet-mediated pedometer-based program improves health-related quality-of-life domains and daily step counts in COPD. Chest. 2015;148(1):128–137. doi:10.1378/chest.14-1466
  • Wan ES, Kantorowski A, Homsy D, et al. Promoting physical activity in COPD: insights from a randomized trial of a web-based intervention and pedometer use. Respir Med. 2017;130:102–110. doi:10.1016/j.rmed.2017.07.057
  • Robinson SA, Cooper JA, Goldstein RL, et al. A randomised trial of a web-based physical activity self-management intervention in COPD. ERJ Open Res. 2021;7:00158–2021. doi:10.1183/23120541.00158-2021
  • Wan ES, Kantorowski A, Polak M, et al. Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations. Respir Med. 2020;162:105878. doi:10.1016/j.rmed.2020.105878
  • Coultas DB, Jackson BE, Russo R, et al. A lifestyle physical activity intervention for patients with chronic obstructive pulmonary disease. A randomized controlled trial. Ann Am Thorac Soc. 2016;13(5):617–626. doi:10.1513/AnnalsATS.201508-508OC
  • Kraemer KM, Litrownik D, Moy ML, et al. Exploring Tai Chi exercise and mind-body breathing in patients with COPD in a randomized controlled feasibility trial. COPD. 2021;18:1–11.
  • Moy ML, Wayne PM, Litrownik D, et al. Long-term Exercise After Pulmonary Rehabilitation (LEAP): a pilot randomised controlled trial of Tai Chi in COPD. ERJ Open Res. 2021;7:00025–2021. doi:10.1183/23120541.00025-2021
  • Yeh GY, Litrownik D, Wayne PM, et al. BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD. BMJ Open Respir Res. 2020;7(1):e000697. doi:10.1136/bmjresp-2020-000697
  • DeLuca ND, Vajta Gomez JP, Vital I, Cahalin LP, Campos MA. The impact of yoga on inspiratory muscle performance in veterans with COPD: a pilot study. Int J Yoga Therap. 2020;31:Article_4.
  • Formiga MF, Vital I, Urdaneta G, Balestrini K, Cahalin LP, Campos MA. The BODE index and inspiratory muscle performance in COPD: clinical findings and implications. SAGE Open Med. 2018;6:2050312118819015. doi:10.1177/2050312118819015
  • O’Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD. 2006;3(4):219–232. doi:10.1080/15412550600977478
  • Collins EG, Jelinek C, O’Connell S, Butler J, Reda D, Laghi F. The effect of breathing retraining using metronome-based acoustic feedback on exercise endurance in COPD: a randomized trial. Lung. 2019;197(2):181–188. doi:10.1007/s00408-019-00198-4
  • Thompson PD, Buchner D, PiñA IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Circulation. 2003;107(24):3109–3116. doi:10.1161/01.cir.0000075572.40158.77
  • Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–1211. doi:10.1378/chest.127.4.1205
  • Ratcliff CG, Barrera TL, Petersen NJ, et al. Recognition of anxiety, depression, and PTSD in patients with COPD and CHF: who gets missed? Gen Hosp Psychiatry. 2017;47:61–67. doi:10.1016/j.genhosppsych.2017.05.004
  • Nguyen HQ, Fan VS, Herting J, et al. Patients with COPD with higher levels of anxiety are more physically active. Chest. 2013;144(1):145–151. doi:10.1378/chest.12-1873
  • Felker B, Bush KR, Harel O, Shofer JB, Shores MM, Au DH. Added burden of mental disorders on health status among patients with chronic obstructive pulmonary disease. Prim Care Companion CNS Disord. 2010;12(4):26595.
  • Felker B, Katon W, Hedrick SC, et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry. 2001;23(2):56–61. doi:10.1016/S0163-8343(01)00127-X
  • Kim HFS, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–471. doi:10.1176/appi.psy.41.6.465
  • Abrams TE, Vaughan-Sarrazin M, Vander Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52(5):441–449. doi:10.1016/j.psym.2011.03.005
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington, VA: American Psychiatric Association; 2013.
  • Budhiraja R, Parthasarathy S, Budhiraja P, Habib MP, Wendel C, Quan SF. Insomnia in patients with COPD. Sleep. 2012;35(3):369–375. doi:10.5665/sleep.1698
  • Brazier JE, Harper R, Jones N, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J. 1992;305(6846):160–164. doi:10.1136/bmj.305.6846.160
  • Wijkstra P, TenVergert E, Van Altena R, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax. 1994;49(5):465–467. doi:10.1136/thx.49.5.465
  • Bamonti P, Jacobs ML. Cognitive late life behavioral therapy in. In: Psychotherapy in Later Life. Cambridge University Press; 2020:35.
  • Cully JA, Stanley MA, Petersen NJ, et al. Delivery of brief cognitive behavioral therapy for medically ill patients in primary care: a pragmatic randomized clinical trial. J Gen Intern Med. 2017;32(9):1014–1024. doi:10.1007/s11606-017-4101-3
  • Renn BN, Hundt NE, Sansgiry S, et al. Integrated brief cognitive behavioral therapy improves illness intrusiveness in veterans with chronic obstructive pulmonary disease. Ann Behav Med. 2018;52(8):686–696. doi:10.1093/abm/kax045
  • Ecker AH, Johnson AL, Sansgiry S, et al. Brief cognitive behavioral therapy reduces suicidal ideation in veterans with chronic illnesses. Gen Hosp Psychiatry. 2019;58:27–32. doi:10.1016/j.genhosppsych.2019.02.002
  • Hundt NE, Bensadon BA, Stanley MA, et al. Coping mediates the relationship between disease severity and illness intrusiveness among chronically ill patients. J Health Psychol. 2015;20(9):1186–1195. doi:10.1177/1359105313509845
  • Brandt CP, Deavers F, Hundt NE, Fletcher TL, Cully JA. The impact of integrating physical health into a brief CBT approach for medically ill veterans. J Clin Psychol Med Settings. 2020;27(2):285–294. doi:10.1007/s10880-019-09634-2
  • Bamonti PM, Wiener CH, Weiskittle RE, et al. The impact of depression and exercise self-efficacy on benefits of pulmonary rehabilitation in veterans with COPD. Behav Med. 2021;1–11. doi:10.1080/08964289.2021.1983755
  • Pirraglia PA, Casserly B, Velasco R, Borgia ML, Nici L. Association of change in depression and anxiety symptoms with functional outcomes in pulmonary rehabilitation patients. J Psychosom Res. 2011;71(1):45–49. doi:10.1016/j.jpsychores.2011.01.002
  • Thapamagar SB, Ellstrom K, Anholm JD, Fargo RA, Dandamudi N. Impact of pulmonary rehabilitation in sleep in COPD patients measured by actigraphy. PLoS One. 2021;16(3):e0248466. doi:10.1371/journal.pone.0248466
  • Kantorowski A, Wan ES, Homsy D, Kadri R, Richardson CR, Moy ML. Determinants and outcomes of change in physical activity in COPD. ERJ Open Res. 2018;4(3). doi:10.1183/23120541.00054-2018
  • Moy ML, Martinez CH, Kadri R, et al. Long-term effects of an internet-mediated pedometer-based walking program for chronic obstructive pulmonary disease: randomized controlled trial. J Med Internet Res. 2016;18(8):e215. doi:10.2196/jmir.5622
  • Pollok J, van Agteren JE, Carson‐Chahhoud KV. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;2018(12). doi:10.1002/14651858.CD012346.pub2
  • Yohannes A, Alexopoulos G. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31(7):483–492. doi:10.1007/s40266-014-0186-0
  • Singh D. Pharmacological treatment of stable chronic obstructive pulmonary disease. Respirology. 2021;26:643–651. doi:10.1111/resp.14046
  • Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go? Eur Respir Rev. 2018;27:149. doi:10.1183/16000617.0022-2018
  • Smith B, Wong CA, Smith TC, Boyko EJ, Gackstetter GD; Team MARftMCS. Newly reported respiratory symptoms and conditions among military personnel deployed to Iraq and Afghanistan: a prospective population-based study. Am J Epidemiol. 2009;170(11):1433–1442. doi:10.1093/aje/kwp287
  • Martinez FJ, Han MK, Allinson JP, et al. At the root: defining and halting progression of early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(12):1540–1551. doi:10.1164/rccm.201710-2028PP
  • Wan ES, Fortis S, Regan EA, et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med. 2018;198(11):1397–1405. doi:10.1164/rccm.201804-0663OC
  • Xia C, Rook M, Pelgrim GJ, et al. Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) study. Eur J Epidemiol. 2020;35(1):75–86. doi:10.1007/s10654-019-00519-0
  • Stockley RA, Halpin DM, Celli BR, Singh D. Chronic obstructive pulmonary disease biomarkers and their interpretation. Am J Respir Crit Care Med. 2019;199(10):1195–1204. doi:10.1164/rccm.201810-1860SO
  • da Silva IRV, de Araujo CLP, Dorneles GP, et al. Exercise-modulated epigenetic markers and inflammatory response in COPD individuals: a pilot study. Respir Physiol Neurobiol. 2017;242:89–95. doi:10.1016/j.resp.2017.04.004
  • Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Chest. 2014;145(3):542–550. doi:10.1378/chest.13-1052
  • Wan ES, Goldstein RL, Garshick E, DeMeo DL, Moy ML. Molecular markers of aging, exercise capacity, & physical activity in COPD. Respir Med. 2021;187:106576. doi:10.1016/j.rmed.2021.106576
  • Chen Z, Fan VS, Belza B, Pike K, Nguyen HQ. Association between social support and self-care behaviors in adults with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2017;14(9):1419–1427. doi:10.1513/AnnalsATS.201701-026OC
  • Lenferink A, van der Palen J, Effing T. The role of social support in improving chronic obstructive pulmonary disease self-management. Expert Rev Respir Med. 2018;12(8):623–626. doi:10.1080/17476348.2018.1489723
  • Vetrovsky T, Frybova T, Gant I, et al. The detrimental effect of COVID‐19 nationwide quarantine on accelerometer‐assessed physical activity of heart failure patients. ESC Heart Failure. 2020;7(5):2093–2097. doi:10.1002/ehf2.12916
  • Wang Y, Zhang Y, Bennell K, et al. Physical distancing measures and walking activity in middle-aged and older residents in Changsha, China, during the COVID-19 epidemic period: longitudinal observational study. J Med Internet Res. 2020;22(10):e21632. doi:10.2196/21632
  • Tuerk PW, Fortney J, Bosworth HB, et al. Toward the development of national telehealth services: the role of Veterans Health Administration and Future Directions for Research. Telemed e-Health. 2010;16(1):115–117. doi:10.1089/tmj.2009.0144
  • Connolly SL, Stolzmann KL, Heyworth L, Weaver KR, Bauer MS, Miller CJ. Rapid increase in telemental health within the Department of Veterans Affairs during the COVID-19 pandemic. Telemed e-Health. 2021;27(4):454–458. doi:10.1089/tmj.2020.0233
  • Darkins A, Ryan P, Kobb R, et al. Care Coordination/Home Telehealth: the systematic implementation of health informatics, home telehealth, and disease management to support the care of veteran patients with chronic conditions. Telemed e-Health. 2008;14(10):1118–1126. doi:10.1089/tmj.2008.0021
  • Holland AE, Mahal A, Hill CJ, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017;72(1):57–65. doi:10.1136/thoraxjnl-2016-208514
  • Grosbois JM, Gicquello A, Langlois C, et al. Long-term evaluation of home-based pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:2037. doi:10.2147/COPD.S90534
  • Drwal KR, Wakefield BJ, Forman DE, Wu W-C, Haraldsson B, El Accaoui RN. Home-based cardiac rehabilitation: experience from the Veterans Affairs. J Cardiopulm Rehabil Prev. 2021;41(2):93–99. doi:10.1097/HCR.0000000000000594
  • Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34. doi:10.1038/nri.2015.5
  • Eagan T, Ueland T, Wagner P, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010;35(3):540–548. doi:10.1183/09031936.00088209
  • Al-Shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res. 2011;12(1):1–6. doi:10.1186/1465-9921-12-3
  • Janssen DJ, Müllerova H, Agusti A, et al. Persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. Respir Med. 2014;108(11):1647–1654. doi:10.1016/j.rmed.2014.07.013
  • Moreira FP, de Azevedo Cardoso T, Mondin TC, et al. The effect of proinflammatory cytokines in Cognitive Behavioral Therapy. J Neuroimmunol. 2015;285:143–146. doi:10.1016/j.jneuroim.2015.06.004
  • Gary RA, Dunbar SB, Higgins MK, Musselman DL, Smith AL. Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res. 2010;69(2):119–131. doi:10.1016/j.jpsychores.2010.01.013
  • Piette JD, Richardson C, Himle J, et al. A randomized trial of telephone counseling plus walking for depressed diabetes patients. Med Care. 2011;49(7):641. doi:10.1097/MLR.0b013e318215d0c9
  • Bade BC, DeRycke EC, Skanderson M, et al. Underutilization of pulmonary function testing in veterans hospitalized for chronic obstructive pulmonary disease exacerbation: who are we missing? COPD. 2020;17(1):15–21. doi:10.1080/15412555.2019.1711036